Friday, June 27, 2025
VISIT ROYALMOK
Agarwood Times
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
No Result
View All Result
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
No Result
View All Result
Agarwood Times
No Result
View All Result

Bayer Looks to Expand Kerendia’s Label to Heart Failure After Phase 3 Win

August 5, 2024
in Health
Reading Time: 2 mins read
0 0
A A
0
Home Health
Share on FacebookShare on Twitter


Bayer’s Kerendia, already FDA authorized in a single cardiometabolic indication, now has information from a pivotal check that help increasing the drug’s label to coronary heart failure.

In preliminary outcomes reported Monday, Bayer stated Kerendia lowered cardiovascular demise and hospitalizations in coronary heart failure sufferers, assembly the primary aim of the Part 3 medical trial. The corporate didn’t launch particular figures detailing the reductions, however stated it’s going to current the medical information subsequent month through the European Society of Cardiology Congress, which might be held in London. Bayer added that it plans to fulfill with the FDA to debate a submission looking for regulatory approval for the drug in coronary heart failure.

Kerendia is a small molecule designed to dam the mineralocorticoid receptor, which performs a job in blood stress regulation. The primary medication developed to dam this receptor are corticosteroids. Kerendia, a non-steroidal drug, was initially authorized by the FDA in 2021 as a therapy for continual kidney illness in sufferers with kind 2 diabetes. The approval particularly covers the discount within the danger of kidney operate decline, kidney failure, or cardiovascular issues — together with hospitalization for coronary heart failure — in these sufferers.

In 2023, Bayer reported €270 million in gross sales for Kerendia, a 152% improve over its gross sales in 2022. Bayer has touted the once-daily tablet’s blockbuster potential as a therapy for each kidney illness and coronary heart failure.

The placebo-controlled Part 3 check in coronary heart failure enrolled about 6,000 sufferers with a prognosis of symptomatic coronary heart failure with left ventricular ejection fraction (LVEF) of 40% or decrease. LVEF is a measure of how a lot blood is pumped out of the guts’s left ventricle. The decrease the LVEF share, the much less blood is pumped out to the remainder of the physique. The 40% mark is beneath the traditional vary and generally is a signal of coronary heart failure. The primary aim of the examine is a composite of cardiovascular demise and complete coronary heart failure occasions, outlined as hospitalizations for coronary heart failure or pressing coronary heart failure visits.

Sufferers within the coronary heart failure trial acquired the examine drug for as much as 42 months. No particulars about Kerendia’s security had been disclosed. Bayer solely stated no new security alerts had been recognized in contrast with these seen in earlier research. Kerendia’s present label features a warning for hyperkalemia, which is elevated potassium ranges within the blood.

“Bayer is set to drive analysis and improvements which have the potential to grow to be therapy choices for illnesses with excessive unmet medical want, together with for sufferers with mildly lowered or preserved ejection fraction,” Christian Rommel, head of analysis and improvement at Bayer’s Prescription drugs Division, stated in a ready assertion.

The 6,000-patient coronary heart failure trial is a part of a broader Bayer medical improvement program for Kerendia projected to enroll about 15,000 sufferers throughout 4 complete research in coronary heart failure. The extra research underway are evaluating Kerendia as a therapy for hospitalized or lately discharged coronary heart failure sufferers; together with an SGLT2 inhibitor, which is a blood sugar-lowering kind 2 diabetes drug, in hospitalized or lately discharged coronary heart failure sufferers; and in coronary heart failure sufferers illiberal to or ineligible for therapy with a steroidal drug.

Picture: Magicmine, Getty Pictures



Source link

Tags: BayerexpandfailureheartKerendiasLabelPhaseWin
Previous Post

Kalimantan oud oil #oudwood #oudoil #oud #agarwood #agarwoodoil #qatar #uae #kuwait #abudhabi

Next Post

US COVID markers continue steady rise

Related Posts

DarioHealth, GreenKey Health partner to expand sleep health program
Health

DarioHealth, GreenKey Health partner to expand sleep health program

June 27, 2025
Covid-19 origin: WHO expert group fails to find a definitive answer
Health

Covid-19 origin: WHO expert group fails to find a definitive answer

June 27, 2025
How dysfunction of a cellular calcium channel affects hearing
Health

How dysfunction of a cellular calcium channel affects hearing

June 27, 2025
New study reveals how nymphaeol A interacts with cell membranes
Health

New study reveals how nymphaeol A interacts with cell membranes

June 27, 2025
Certify Raises M To Advance Healthcare Provider Data Infrastructure
Health

Certify Raises $40M To Advance Healthcare Provider Data Infrastructure

June 27, 2025
RFK Jr’s New Advisory Panel Votes Against Vaccine Preservative Following Pitch From Ex-President of RFK Jr’s Anti-Vaxx Org
Health

RFK Jr’s New Advisory Panel Votes Against Vaccine Preservative Following Pitch From Ex-President of RFK Jr’s Anti-Vaxx Org

June 27, 2025
Next Post
US COVID markers continue steady rise

US COVID markers continue steady rise

Agarwood selling market/ Agar tree and oudh selling market/ India’s biggest agarwood market

Agarwood selling market/ Agar tree and oudh selling market/ India's biggest agarwood market

Rising toll of serious injuries linked to expanded Mexico-US border wall crossing

Rising toll of serious injuries linked to expanded Mexico-US border wall crossing

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Measles cases confirmed in Washington, Virginia
Diseases

Measles cases confirmed in Washington, Virginia

by admin
June 26, 2025
0

Stan Lupo / Flickr cc An annual survey from the Maryland Division of Pure Sources revealed that 62 white-tailed deer...

DarioHealth, GreenKey Health partner to expand sleep health program

DarioHealth, GreenKey Health partner to expand sleep health program

June 27, 2025
RFK Jr Admits He ‘Did Not Fact Check’ MAHA Report Before Non-Existent Sources Were Found in the Paper

RFK Jr Admits He ‘Did Not Fact Check’ MAHA Report Before Non-Existent Sources Were Found in the Paper

June 25, 2025
How To Unclog Pores, From Experts

How To Unclog Pores, From Experts

June 22, 2025
Srilaka#Sailanka#Wholesaleprice#Retails#العود#Saidiarabia#Dubai#AllquaLITYSAVAILABLE#Shorts

Srilaka#Sailanka#Wholesaleprice#Retails#العود#Saidiarabia#Dubai#AllquaLITYSAVAILABLE#Shorts

June 26, 2025
How to Grill Tofu – Sharon Palmer, The Plant Powered Dietitian

How to Grill Tofu – Sharon Palmer, The Plant Powered Dietitian

June 26, 2025
Facebook Twitter Instagram Youtube RSS
Agarwood Times

Stay informed with the latest news, articles, and insights on agarwood cultivation, history, sustainability, and more. Explore the timeless allure of agarwood and deepen your understanding of this extraordinary natural resource.

CATEGORIES

  • Agarwood
  • Diet & Fitness
  • Diseases
  • Health
  • Meditation
  • Nutrition
  • Sleep Info
  • Uncategorized
No Result
View All Result

SITEMAP

  • About us
  • Advertise With Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
VISIT ROYALMOK

Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In